Skip to Content
  • Previous Rank
    145
  • Revenues ($M)
    $22,561.0
  • Revenue Percent Change
    8.6%
  • Profits ($M)
    $4,920.0
  • Profits Percent Change
    388.6%
  • Assets ($M)
    $34,986.0
  • Employees
    23,300

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, psychiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Company Info

CEO
Giovanni Caforio
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New York, N.Y.
Websitehttp://www.bms.com
Years on Fortune 500 List65
Employees23,300
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

Bristol-Myers Squibb Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,561.08.6%
Profits ($M)$4,920.0388.6%
Assets ($M)$34,986.0-
Total Stockholder Equity ($M)$14,031.0-

Profit Ratios

Profit as % of Revenues21.8%
Profits as % of Assets14.1%
Profits as % of Stockholder Equity35.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.01
EPS % Change (from 2017)393.4%
EPS % Change (5 year annual rate)14.3%
EPS % Change (10 year annual rate)1.4%

Total Return

Total Return to Investors (2018)-12.7%
Total Return to Investors (5 year, annualized)2.2%
Total Return to Investors (10 year, annualized)12.3%